Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.12.24 | Nasdaq Stockholm AB: Listing of Intea Fastigheter AB (publ) on Nasdaq Stockholm | 120 | GlobeNewswire (Europe) | Nasdaq Stockholm AB has assessed that Intea Fastigheter AB (publ), company registration number 559027-5656, fulfills Nasdaq Stockholm's listing requirements. Provided that Intea Fastigheter AB (publ)... ► Artikel lesen | |
06.12.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Tangiamo Touch Technology AB | 229 | GlobeNewswire (Europe) | Referring to the press release from Tangiamo Touch Technology AB from December 5, 2024, the company will carry out a reverse stock split in relations 1:1000. The share will be traded under new ISIN... ► Artikel lesen | |
06.12.24 | Covenant Logistics Group, Inc.: Covenant Logistics Group Announces Two-For-One Stock Split | 294 | GlobeNewswire (Europe) | CHATTANOOGA, Tenn., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) ("Covenant" or the "Company") announced today that its board of directors has declared a two-for-one... ► Artikel lesen | |
06.12.24 | Athira Pharma, Inc.: Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND | 306 | GlobeNewswire (Europe) | BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and... ► Artikel lesen | |
06.12.24 | Zevra Therapeutics Announces Organizational Changes | 231 | GlobeNewswire (Europe) | CELEBRATION, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment... ► Artikel lesen | |
06.12.24 | BioAge Labs, Inc.: BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity | 223 | GlobeNewswire (Europe) | Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients enrolled to date and share updated... ► Artikel lesen | |
06.12.24 | Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4) | 305 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) ("Cerence AI"), a global industry leader in AI for transportation, today announced that, in connection with Antonio... ► Artikel lesen | |
06.12.24 | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 334 | GlobeNewswire (Europe) | BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
06.12.24 | Osisko Metals Incorporated: Osisko Metals Acquires Additional Claims Near Gaspé Copper | 217 | GlobeNewswire (Europe) | MONTREAL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce the acquisition of a group... ► Artikel lesen | |
06.12.24 | Dynamix Corporation Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing December 9, 2024 | 158 | GlobeNewswire (Europe) | Houston, TX, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Dynamix Corporation (the "Company") today announced that commencing December 9, 2024, holders of the units sold in the Company's initial public offering... ► Artikel lesen | |
06.12.24 | Freight App, Inc.: Freight Technologies Provides Update on its Public Filings Procedures | 262 | GlobeNewswire (Europe) | HOUSTON, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, "Fr8Tech" or the "Company"), a logistics management innovation company, offering a diverse portfolio of technology-driven... ► Artikel lesen | |
06.12.24 | Codexis, Inc.: Codexis Announces New Employment Inducement Grants | 224 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced... ► Artikel lesen | |
06.12.24 | Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 218 | GlobeNewswire (Europe) | WALTHAM Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved... ► Artikel lesen | |
06.12.24 | Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 170 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on December 4, 2024, the Compensation Committee of Adverum's Board of Directors... ► Artikel lesen | |
06.12.24 | NurExone Biologic Inc: NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage | 307 | GlobeNewswire (Europe) | TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing... ► Artikel lesen | |
06.12.24 | Chimerix, Inc.: Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 277 | GlobeNewswire (Europe) | DURHAM, N.C., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on December 2, 2024, the Compensation Committee of Chimerix's Board of Directors granted inducement awards... ► Artikel lesen | |
06.12.24 | Xenon Pharmaceuticals Inc.: Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 | 213 | GlobeNewswire (Europe) | - OLE data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent AE safety profile suggesting long-term efficacy and tolerability of azetukalner... ► Artikel lesen | |
06.12.24 | NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 118 | GlobeNewswire (Europe) | NAARDEN, The Netherlands and MIAMI, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company... ► Artikel lesen | |
06.12.24 | Arcutis Biotherapeutics, Inc.: Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 189 | GlobeNewswire (Europe) | WESTLAKE VILLAGE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen | |
06.12.24 | Credit Agricole Sa: Crédit Agricole entered into financial instruments relating to 5.2% of Banco BPM's share capital | 224 | GlobeNewswire (Europe) | Montrouge, 6th december 2024 Crédit Agricole entered into financial instruments relating to 5.2% of Banco BPM's share capital Crédit Agricole S.A. ("Crédit Agricole") has notified the Italian Authority... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 3.006 |
APPLE | 2.123 |
STEYR MOTORS | 1.945 |
RHEINMETALL | 1.714 |
BYD | 1.526 |
RENK GROUP | 1.288 |
TESLA | 1.239 |
TUI | 1.189 |
DEUTZ | 1.100 |
NEL | 887 |
NOVO NORDISK | 732 |
EVOTEC | 727 |
INFINEON | 701 |
BASF | 669 |
BAYER | 624 |
MERCEDES-BENZ | 616 |
DEUTSCHE BANK | 606 |
XIAOMI | 599 |
THYSSENKRUPP | 565 |
MUTARES | 564 |
COMMERZBANK | 555 |
AMAZON | 553 |
VOLKSWAGEN | 553 |
ALLIANZ | 552 |
DEUTSCHE TELEKOM | 551 |